News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
437,117 Results
Type
Article (29056)
Company Profile (159)
Press Release (407888)
Multimedia
Podcasts (120)
Webinars (17)
Section
Business (128240)
Career Advice (1269)
Deals (23070)
Drug Delivery (117)
Drug Development (61282)
Employer Resources (123)
FDA (9945)
Job Trends (9701)
News (226608)
Policy (21156)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1534)
Academic (1)
Accelerated approval (20)
Adcomms (25)
Allergies (103)
Alliances (33803)
ALS (122)
Alzheimer's disease (1062)
Antibody-drug conjugate (ADC) (225)
Approvals (10151)
Artificial intelligence (336)
Autoimmune disease (96)
Automation (21)
Bankruptcy (206)
Best Places to Work (7181)
BIOSECURE Act (14)
Biosimilars (179)
Biotechnology (68)
Bladder cancer (90)
Brain cancer (40)
Breast cancer (369)
Cancer (2918)
Cardiovascular disease (307)
Career advice (1059)
Career pathing (29)
CAR-T (158)
CDC (29)
Celiac Disease (1)
Cell therapy (398)
Cervical cancer (18)
Clinical research (53334)
Collaboration (1146)
Company closure (2)
Compensation (405)
Complete response letters (53)
COVID-19 (1825)
CRISPR (58)
C-suite (598)
Cystic fibrosis (99)
Data (4167)
Decentralized trials (2)
Denatured (33)
Depression (104)
Diabetes (340)
Diagnostics (3066)
Digital health (18)
Diversity (12)
Diversity, equity & inclusion (36)
Drug discovery (187)
Drug pricing (205)
Drug shortages (34)
Duchenne muscular dystrophy (163)
Earnings (48338)
Editorial (57)
Employer branding (14)
Employer resources (116)
Events (63148)
Executive appointments (715)
FDA (11880)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (844)
Gene editing (110)
Generative AI (35)
Gene therapy (354)
GLP-1 (908)
Government (2709)
Grass and pollen (6)
Guidances (250)
Healthcare (9587)
HIV (46)
Huntington's disease (34)
IgA nephropathy (62)
Immunology and inflammation (198)
Immuno-oncology (43)
Indications (78)
Infectious disease (2003)
Inflammatory bowel disease (144)
Inflation Reduction Act (12)
Influenza (66)
Intellectual property (144)
Interviews (192)
IPO (9350)
IRA (55)
Job creations (2733)
Job search strategy (929)
JPM (56)
Kidney cancer (10)
Labor market (66)
Layoffs (389)
Leadership (31)
Legal (4991)
Liver cancer (54)
Longevity (10)
Lung cancer (392)
Lymphoma (251)
Machine learning (26)
Management (46)
Manufacturing (573)
MASH (127)
Medical device (4712)
Medtech (4736)
Mergers & acquisitions (14370)
Metabolic disorders (1037)
Multiple sclerosis (122)
NASH (21)
Neurodegenerative disease (200)
Neuropsychiatric disorders (76)
Neuroscience (1950)
Neurotech (1)
NextGen: Class of 2026 (3721)
Non-profit (2182)
Now hiring (46)
Obesity (559)
Opinion (246)
Ovarian cancer (95)
Pain (166)
Pancreatic cancer (121)
Parkinson's disease (197)
Partnered (26)
Patents (290)
Patient recruitment (293)
Peanut (31)
People (41950)
Pharmaceutical (79)
Pharmacy benefit managers (33)
Phase 1 (16037)
Phase 2 (22850)
Phase 3 (18503)
Pipeline (3376)
Policy (259)
Postmarket research (1950)
Preclinical (5897)
Press Release (50)
Prostate cancer (171)
Psychedelics (33)
Radiopharmaceuticals (202)
Rare diseases (612)
Real estate (3864)
Recruiting (50)
Regulatory (16434)
Reports (30)
Research institute (1484)
Resumes & cover letters (187)
Rett syndrome (7)
RNA editing (12)
RSV (57)
Schizophrenia (127)
Series A (152)
Series B (110)
Service/supplier (9)
Sickle cell disease (75)
Special edition (21)
Spinal muscular atrophy (134)
Sponsored (23)
Startups (2561)
State (2)
Stomach cancer (13)
Supply chain (80)
Tariffs (94)
The Weekly (85)
Vaccines (664)
Venture capital (78)
Weight loss (402)
Women's health (53)
Worklife (12)
Date
Last 7 days (371)
Last 30 days (1218)
Last 365 days (18418)
2026 (1714)
2025 (18729)
2024 (21589)
2023 (24175)
2022 (32034)
2021 (33974)
2020 (32292)
2019 (27761)
2018 (21436)
2017 (21675)
2016 (20775)
2015 (24354)
2014 (18604)
2013 (15348)
2012 (16583)
2011 (17175)
2010 (15516)
Location
Africa (543)
Alabama (45)
Alaska (4)
Arizona (131)
Arkansas (8)
Asia (31207)
Australia (4543)
California (5940)
Canada (2074)
China (858)
Colorado (235)
Connecticut (242)
Delaware (207)
Europe (67813)
Florida (1021)
Georgia (185)
Hawaii (2)
Idaho (32)
Illinois (559)
India (59)
Indiana (352)
Iowa (7)
Japan (352)
Kansas (89)
Kentucky (31)
Louisiana (15)
Maine (15)
Maryland (793)
Massachusetts (4558)
Michigan (103)
Minnesota (325)
Mississippi (3)
Missouri (64)
Montana (15)
Nebraska (17)
Nevada (56)
New Hampshire (19)
New Jersey (2096)
New Mexico (24)
New York (1663)
North Carolina (917)
North Dakota (2)
Northern California (2812)
Ohio (172)
Oklahoma (10)
Oregon (26)
Pennsylvania (1297)
Puerto Rico (19)
Rhode Island (28)
South America (794)
South Carolina (19)
Southern California (2458)
Tennessee (79)
Texas (848)
United States (22338)
Utah (130)
Virginia (195)
Washington D.C. (64)
Washington State (520)
West Virginia (1)
Wisconsin (58)
Wyoming (2)
437,117 Results for "merz pharma group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merz Therapeutics Appoints Dan Staner as President, Region Europe
January 30, 2026
·
2 min read
Press Releases
Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity
January 26, 2026
·
3 min read
Press Releases
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 2026
December 8, 2025
·
3 min read
Press Releases
LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES
January 29, 2026
·
3 min read
Mergers & acquisitions
Big Pharma Dealmakers Joined by Spunky Group of Biotech Buyers in Q4
While Novartis secured the biggest deal of the fourth quarter, a handful of riveting tales emerged from the bottom of the M&A list, including a zombie buyout and a bidding war. And no, we’re not talking about Metsera.
January 2, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Merz Therapeutics Expands Presence with New Affiliate in Poland
October 8, 2025
·
2 min read
Press Releases
LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZED $12M OFFERING
December 24, 2025
·
6 min read
Press Releases
Merz Aesthetics® Introduces New BELOTERO® Syringe Offering Greater Precision, Comfort and Ease of Use
November 3, 2025
·
5 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Press Releases
LSL PHARMA GROUP REPORTS FOURTH CONSECUTIVE RECORD QUARTERLY REVENUES AND Q3 2025 FINANCIAL RESULTS
November 21, 2025
·
16 min read
1 of 43,712
Next
